Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medication
Autor: | Elnaz Faramarzi, Nayyer Jaberi, Mostafa Farahbakhsh, alireza Ostadrahimi, Mohammad Asghari Jafarabadi, Ali Fakhari |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: | |
Zdroj: | Caspian Journal of Internal Medicine, Vol 11, Iss 3, Pp 310-314 (2020) |
Druh dokumentu: | article |
ISSN: | 2008-6164 2008-6172 |
Popis: | Background: This study was conducted to determine the prevalence of metabolic syndrome (Mets) in schizophrenic patients in a 6-month period of treatment with antipsychotic medications. Methods: In this study, 60 volunteer schizophrenic patients were included. At the onset and 6 months after treatment with antipsychotic medications, fasting blood sugar (FBS), serum triglyceride (TG), high density lipoprotein (HDL), weight, waist circumference (WC), and blood pressure were determined. We defined Mets according to ATPIII criteria. Results: After a 6-month treatment with antipsychotic drugs, the mean WC, serum TG, HDL, systolic and diastolic blood pressure increased but the changes of WC and HDL were statistically significant (p |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |